In addition, Scheibe et al. showed an increase number of intestinal IL-36α+ Mfs in IBD patients, which correlated with the degree of inflammation (297) and the accumulation of αSMA+ myofibroblasts (298). The gene discussed is IL36A; the disease is inflammatory bowel disease.